Skip navigation

Applying the Latest Technical and Process Innovations to Achieve Commercially Viable Products and Efficacious Patient Outcomes

March 26-27, 2018
  • Washington, DC


There has been a tremendous amount of progress in the development of cell and gene therapies, which would not be possible without the application of novel tools, technologies and techniques to develop the processes required to manufacture these revolutionary products. As such, CBI’s Bioprocessing Series is proud to present Optimization of Cell & Gene Therapy Production
A revolutionary event focused on the technical and process innovations that are now yielding clinical and commercial success and the collaborative, industry-wide effort to overcome the tremendous bioprocessing obstacles and bottlenecks facing this field.

Utilizing a single-track format, this event will serve as a platform to unite leading developers and end users to collectively tackle the specific process and production challenges in one room — Not separated into several tracks in a trade show-like setup. This streamlined format paves the way for a variety of interactive formats that encourage participation and maximize the conference experience for every attendee.

The Most Comprehensive Clinical Translational Meeting Focused on:

  • Developing Technologies to Improve Manufacturing Workflows
  • Achieving Commercially Ready Processes through Automation
  • Utilizing Genomics and Gene Editing Tools to Develop
    Stem Cell Therapies
  • Maximizing Scalability of Analytical Methods from R&D to
    Clinical Manufacturing
  • Ensuring Process Robustness with More Cost-Efficient Approaches
  • Determining the Least Risky Strategies for Commercialization



This conference is a fantastic forum to interact with
experts from a large cross-section of the Cell
and Gene Therapy industry.

Lead Scientist, Analytical Development, Cell and Gene Therapy Catapult, UK

Excellent opportunity to learn from and share experiences with industry leaders shaping the future of cell therapy.

Director, Cell Therapy Operations, Lonza Walkersville

This conference provides for the ability to interact with
the leaders in the field of Cell and Gene Therapy to
discuss novel applications to solve common issues
for commercial manufacturing.

Director, Analytical R&D, Cell Process Development, Celgene

CBI’s Optimization of Cell & Gene Therapy Production rises to the top of our meeting to attend list because of it’s ability to address the specific challenges manufacturers face in the rapidly advancing cell and gene therapy field.

General Manager, Cell Therapy Growth Strategy, GE Healthcare